Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
NEW YORK, March 27, 2023 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business... | March 27, 2023
Source: marketscreener.com